Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018

Posted on: 02 Jan 18

RANCHO CORDOVA, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (“Cesca”) (NASDAQ:KOOL) a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Chris Xu, Ph.D., chief executive officer, will be presenting at Biotech Showcase on Tuesday, January 9, 2018 at 4:00pm PST. The conference is being held January 8-10, 2018 at the Hilton San Francisco Union Square.

A live webcast of the presentation will be available at: The webcast will be archived for 90 days.

About Cesca Therapeutics Inc. 
Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca is also leveraging its proprietary AutoXpress® technology platform to develop an automated, functionally-closed CAR-TXpress platform that addresses cellular manufacturing needs in the immuno-oncology field.

Company Contact:
Cesca Therapeutics Inc.
Wendy Samford

Investor Contact:
Rx Communications
Paula Schwartz


Last updated on: 02/01/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.